Shandong Sito Bio-technology Co., Ltd. (SHE:300583)

China · Delayed Price · Currency is CNY

13.83

-0.08 (-0.58%)

Sep 23, 2026, 3:04 PM CST

Market Cap	2.62B -9.8%
Revenue (ttm)	1.12B +23.0%
Net Income	9.77M
EPS	0.05
Shares Out	189.70M
PE Ratio	266.12
Forward PE	n/a
Dividend	0.02 (0.11%)
Ex-Dividend Date	Jul 14, 2026

Volume	3,440,800
Open	13.91
Previous Close	13.91
Day's Range	13.72 - 13.95
52-Week Range	10.63 - 16.27
Beta	0.14
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHE:300583

Shandong Sito Bio-technology Co., Ltd. researches, develops, and produces steroid biomedicine intermediates. Its products include 9α-hydroxyandrost, 17α-hydroxyprogesterone, 17α-hydroxy progesterone derivatives, anecort acetate, bis-decyl alcohol (BA), neomycin sulfate, progesterone intermediate, tylvalosin tartrate, tetraene acetate, androstenedione, bisnoralcohol, norandrostenedione, 16β and 16α methyl epoxide, and hexahydro-3a-methyl, as well as androsta-1,4-diene-3,17-dione and estra-4,9-diene-3,17-dione. It also provides APIs for animal he... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2002

Employees 990

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300583

Full Company Profile

Financial Performance

In 2025, SHE:300583's revenue was 1.02 billion, an increase of 4.77% compared to the previous year's 970.60 million. Losses were -73.15 million, -17.60% less than in 2024.

Financial Statements